Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,745 USD | -2,61% | -0,33% | -6,17% |
Omzet 2024 * | 30,79 mln. 28,8 mln. | Omzet 2025 * | 11,82 mln. 11,06 mln. | Marktkapitalisatie | 75,7 mln. 70,81 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -63 mln. -58,94 mln. | Nettowinst (verlies) 2025 * | -84 mln. -78,58 mln. | EV/omzet 2024 * | 2,46 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 6,4 x |
K/w-verhouding 2024 * |
-1,65
x | K/w-verhouding 2025 * |
-1,56
x | Werknemers | 165 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 78,46% |
Recentste transcriptie over HOOKIPA Pharma Inc.
1 dag | -2,61% | ||
1 week | -0,33% | ||
Lopende maand | +6,74% | ||
1 maand | +8,17% | ||
3 maanden | +5,82% | ||
6 maanden | +66,48% | ||
Lopend jaar | -6,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 01-06-16 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 01-04-17 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-02-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 01-06-16 |
Chairman | 63 | 01-10-17 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 01-04-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 0,7698 | +0,63% | 8 178 615 |
23-04-24 | 0,765 | +8,20% | 791 938 |
22-04-24 | 0,707 | -3,55% | 872 297 |
19-04-24 | 0,733 | -4,17% | 443 545 |
18-04-24 | 0,7649 | +0,31% | 172 841 |
uitgestelde koers Nasdaq, 24 april 2024 om 16:42 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,17% | 75,7 mln. | |
+25,57% | 672 mld. | |
+26,04% | 570 mld. | |
-6,02% | 360 mld. | |
+15,75% | 321 mld. | |
+8,37% | 300 mld. | |
+6,75% | 217 mld. | |
-9,33% | 204 mld. | |
+5,20% | 199 mld. | |
-9,22% | 149 mld. |